1. Home
  2. MRUS vs YELP Comparison

MRUS vs YELP Comparison

Compare MRUS & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • YELP
  • Stock Information
  • Founded
  • MRUS 2003
  • YELP 2004
  • Country
  • MRUS Netherlands
  • YELP United States
  • Employees
  • MRUS N/A
  • YELP N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • YELP Other Consumer Services
  • Sector
  • MRUS Health Care
  • YELP Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • YELP Nasdaq
  • Market Cap
  • MRUS 2.9B
  • YELP 2.5B
  • IPO Year
  • MRUS 2016
  • YELP 2012
  • Fundamental
  • Price
  • MRUS $39.45
  • YELP $40.69
  • Analyst Decision
  • MRUS Strong Buy
  • YELP Hold
  • Analyst Count
  • MRUS 12
  • YELP 8
  • Target Price
  • MRUS $87.92
  • YELP $37.17
  • AVG Volume (30 Days)
  • MRUS 706.1K
  • YELP 735.2K
  • Earning Date
  • MRUS 02-26-2025
  • YELP 02-13-2025
  • Dividend Yield
  • MRUS N/A
  • YELP N/A
  • EPS Growth
  • MRUS N/A
  • YELP 29.71
  • EPS
  • MRUS N/A
  • YELP 1.64
  • Revenue
  • MRUS $35,932,000.00
  • YELP $1,392,488,000.00
  • Revenue This Year
  • MRUS N/A
  • YELP $6.80
  • Revenue Next Year
  • MRUS $57.37
  • YELP $5.39
  • P/E Ratio
  • MRUS N/A
  • YELP $24.87
  • Revenue Growth
  • MRUS N/A
  • YELP 6.80
  • 52 Week Low
  • MRUS $31.62
  • YELP $32.56
  • 52 Week High
  • MRUS $61.61
  • YELP $45.91
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 38.07
  • YELP 63.35
  • Support Level
  • MRUS $38.52
  • YELP $37.96
  • Resistance Level
  • MRUS $47.75
  • YELP $40.47
  • Average True Range (ATR)
  • MRUS 2.05
  • YELP 0.80
  • MACD
  • MRUS -0.17
  • YELP 0.08
  • Stochastic Oscillator
  • MRUS 16.83
  • YELP 93.54

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

Share on Social Networks: